Your search found 2 Results
[Main objectives of the WHO Special Program on Human Reproduction] Osnovnye napravleniia Spetsialnoi Programmy VOZ po Reproduktsii Cheloveka.
AKUSHERSTVO I GINEKOLOGIIA. 1984 Jul; (7):3-6.The WHO Special Program on Human reproduction was established in 1972 to coordinate international research on birth control, family planning, development of effective methods of contraception, and treatments for disorders of the human reproductive system. The Program's main objectives are: implementation of family planning programs at primary health care facilities, evaluation of the safety and effectiveness of existing birth control methods, development of new birth control methods, and development of new methods of sterility treatment. In order to attain these goals, the Program forth 3 major tasks for international research: 1) psychosociological aspects of family planning, 2) birth control methods, and 3) studies on sterility. Since most of the participating nations belong to the 3rd World, the Program is focused on human reproduction in developing countries. The USSR plays an important role in the WHO Special Program on Human reproduction. A WHO Paticipating Center has been established at the All-Union Center for Maternal and Child Care in Moscow. Soviet research concentrates on 3 major areas: diagnosis and treatment of female sterility, endocrinological aspects of contraception, and birth control prostaglandins.
WHO Special Programme of Research, Development and Research Training in Human Reproduction (HRP): summary review of programme activities and recommendations on future policies and management. Report by the SAREC reference group for HRP, November 1982.
Stockholm, Sweden, SAREC, 1983 Apr.  p.This document, a summary view of the Reference Group for Human Reproduction (HRP) developments and achievements over the years, is based on the consideration of results from the 1981 assessment of the program by the Swedish Agency for Research Cooperation (SAREC). An attempt is made to outline broadly the responsibility of the World Health Organization (WHO) in the field of human reproduction research and family planning at large and to define the specific role and time perspective of HRP as a special program. Sweden played an active role in the creation of HRP and since the start has financed a substantial part of the project. HRP was established as a Special Program within WHO, implying the existence of a specific task and a time horizon. HRP was created in 1971, a time of rapidly increasing international efforts to encourage family planning activities in developing nations. Its objectives included contributing to the development of safe and effective contraceptive methods suitable for widespread use especially in the developing countries. Program objectives and activities have grown more complex. HRP activities now include the clinical testing of current contraceptive methods and methods in development, development of new contraceptive methods, health services research, a program of research on infertility, and the strengthening of national scientific resources. HRP has created a network of centers for clinical testing in a number of countries. This network has made possible the testing of methods in different social, cultural, and nutritional settings. To clinical tests of contraceptives should be added assessments of health services implications of the introduction of the methods, including the medical services needed for treatment of risk cases. While not in itself responsible for supporting basic research as a major activity, HRP could play an initiating and mediating role in the contraceptive research and development process. This role should focus on strengthening the links between research strategy and actual experience of family planning in developing countries. In terms of the HRP management structure, the program needs a new structure, one which clearly defines the responsibility for making decisions in different respects and provides for a direct and balanced influence of both developing countries and donors.